Product Information
ROPINIROLE HCL ER 2 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.3788 per EA under NDC 00228365803. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on May 17, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228365803
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA090869FDA Approved
5/17/2012
TE Code
AB
On Market Since
8/23/2012
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL ER 2 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 78.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3788 per EA |
|---|---|
| All-time high | $2.0158 (Feb 12, 2014) |
| All-time low | $0.3647 (Nov 20, 2024) |
| 52-week high | $0.5217 |
| 52-week low | $0.3788 |
| Median price | $0.7869 |
| Average price | $0.8748 |
| Largest weekly change | +51.2% (Apr 18, 2018) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 82% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL ER 2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL ER 2 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.3788 per EA (NDC 00228365803), effective Aug 19, 2026.
How has the price of ROPINIROLE HCL ER 2 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL ER 2 MG TABLET has declined 78.4%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL ER 2 MG TABLET?
Since Nov 28, 2013, the NADAC for ROPINIROLE HCL ER 2 MG TABLET has ranged from a low of $0.3647 (Nov 20, 2024) to a high of $2.0158 (Feb 12, 2014), with a median of $0.7869 per EA.
Are there cheaper alternatives to ROPINIROLE HCL ER 2 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ROPINIROLE HCL 2 MG TABLET, is $0.0664 per EA — about 82% below ROPINIROLE HCL ER 2 MG TABLET.
Who manufactures ROPINIROLE HCL ER 2 MG TABLET?
ROPINIROLE HCL ER 2 MG TABLET (NDC 00228365803) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.